Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
Nanoscale · 2024 · 16 (14) · 6820-6836
DOI: 10.1039/d4nr00019f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2024. Verfasst von Yeung Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, NYU Tandon School of Engineering, New York University, USA. irene.delazaro@nyu.edu. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles, Liposomes. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 149 Literaturangaben. Gefördert von: New York University.
Abstract (Originalsprache)
This review highlights the latest advances in lipid nanoparticle mRNA based nanomedicines under preclinical and clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, NYU Tandon School of Engineering, New York University, USA. irene.delazaro@nyu.edu.
- Cardiovascular Research Center, Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York University, USA.
- Harvard John A. Paulson School of Engineering and Applied Science, Harvard University, USA.
Förderung
- New York University
Zitieren
APA
Wu, Y., Yu, S., & de Lázaro, I. (2024). Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines. Nanoscale, 16(14), 6820-6836. https://doi.org/10.1039/d4nr00019f
Vancouver
Wu Y, Yu S, de Lázaro I. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines. Nanoscale. 2024;16(14):6820-6836. doi:10.1039/d4nr00019f
BibTeX
@article{Wu2024,
author = {Wu, Yeung and Yu, Sinuo and de Lázaro, Irene},
title = {Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines},
journal = {Nanoscale},
year = {2024},
volume = {16},
number = {14},
pages = {6820--6836},
doi = {10.1039/d4nr00019f}
}
EUVIMED